Impact of ACPA and RF titers and their reduction on therapeutic response after one year in rheumatoid arthritis patients
Reductions in RF and ACPA occurred in nearly half of patients, correlating with improved clinical outcomes. Shorter disease duration, use of TNFb were key predictors of antibody reduction.
Authors
- Clementina López‐Medina (ORCID: https://orcid.org/0000-0002-2309-5837)
- Juan Carlos Arguello (ORCID: https://orcid.org/0000-0003-1494-1146)
- Ronald Perez (ORCID: https://orcid.org/0000-0003-3704-486X)
- Rodrigo Nicolás Garcia Salinas (ORCID: https://orcid.org/0000-0002-5928-1092)
- Santiago Ruta (ORCID: https://orcid.org/0000-0002-4071-7300)
- Sebastián Magri (ORCID: https://orcid.org/0009-0005-5433-2726)
Institutions
- Hospital Italiano La Plata (AR)
- Hospital Universitario Reina Sofía (ES)
Publication Details
- Journal
- ARP Rheumatology
- Published
- 2025-09-28
- DOI
- https://doi.org/10.63032/prhn3564
- Primary Topic
- Rheumatoid Arthritis Research and Therapies
- Type
- article
- Field-Weighted Citation Impact
- 0.00